Characteristics of the study group | CAIG group (n = 27) | IG group (n = 53) | NPfDG group (n = 23) | P-value |
---|---|---|---|---|
Symptomatic Pf infection (median Q1–Q3) | 2 (0–4) | 2 (1–3) | 0.209a | |
Asymptomatic Pf infection (median Q1–Q3) | 2.5 (1–4) | 1 (0–1) | < 0.001a | |
Mothers | ||||
Number of infants. (Median Q1–Q3) | 3 (1–4) | 3 (2–5) | 4 (2–6) | 0.386C |
Maternal age (median Q1–Q3) | 26 (22–30) | 27.5 (23–30) | 31 (29–35) | 0.001C |
Number of antenatal visits (Median Q1–Q3) | 3 (2–4) | 3 (1–5) | 5 (4–6) | 0.005C |
Number of Preventive malaria treatment (median Q1–Q3) | 1 (0–1) | 1 (1–1) | 1 (1–1) | 0.514C |
Infants | ||||
Birth weight (Median Q1–Q3) | 2901 (2702.5–3212.5) | 2957.5 (2637.5–3162.5) | 3175 (2860–3315) | 0.086C |
Ethnic group (n. %): | 0.121b | |||
Aïzo | 17 (68) | 42 (79) | 15 (65) | |
Fon | 5 (20) | 7 (13) | 2 (7) | |
Others | 3 (12) | 3 (8) | 6 (28) | |
Bednet possession (Median Q1–Q3) | 1 (0–1) | 1 (0–1) | 1 (1–1) | 0.049C |
HbS (n. %): | < 0.001b | |||
AA | 14 (56) | 38 (81) | 20 (87) | |
AS | 10 (40) | 9 (19) | 3 (13) | |
SS | 1 (4) | 0 (0) | 0 (0) | |
Bednet use for infants (Median Q1–Q3) | ||||
Score ranging from 1 (rare use) to 4 (frequent use) | 4 (3–4) | 4 (3–4) | 3 (3– 4) | 0.429C |